Skip to content

Ayurvedic management of avascular necrosis of femur head (AVN)

Multimodal Ayurvedic Management of Avascular Necrosis of Femur Head (Asthiksaya). A Pre-post designed Single Arm Clinical Study. - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/066203
Enrollment
10
Registered
2024-04-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M879- Osteonecrosis, unspecified

Interventions

None listed

Sponsors

JS ayurved mahavidyalaya and PD patel ayurved hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a) Patients who fulfil any two of the above said symptoms. b) Patients of age between 20-50 years and of both the gender. c) Confirmed diagnosis through MRI (grade I, II and III- Ficat and Arlet classification) or X-ray

Exclusion criteria

Exclusion criteria: a) Female patients having pregnancy or lactating period. b) Patient with associated disease which affects the outcomes or completion of the treatment i.e., cardiovascular disorders, hypothyroidism, obesity (BMI=35), cancer, tuberculosis, heart diseases, rheumatoid arthritis and psoriatic arthritis. c) MRI finding showing avascular necrosis (AVN) of femur head of grade IV (Ficat and Arlet classification).

Design outcomes

Primary

MeasureTime frame
1)to find out the changes in VAS scale of pain. 2)Changes obtained in Harris-Hip Score.Timepoint: base line and after 1 month of treatment.

Secondary

MeasureTime frame
1)find out the changes in range of motion of hip joint and gait of a patient.Timepoint: base line and after 1 month of treatment.

Countries

India

Contacts

Public ContactDr Dhaval Dholakiya

JS ayurved mahavidyalaya and PD patel ayurved hospital

ms.poojasuthar2297@gmail.com9619484565

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026